IL1B and prostate carcinoma: Notably, the conditioning of the bone metastatic niche by IL-1β secreted by PC3-ML cells supported the survival and growth of prostate cancer cells such as LNCaP cells (growing within the same skeletal tumors) that otherwise would have failed to colonize the bone.